Drawing for ZIGMA

USPTO serial 85766332

ZIGMA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
CARL III, FRED
Law office

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZIGMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sheldon R. Pontaoe

DENISE VIVAR ALCON LABORATORIES, INC.6201 SOUTH FWYFORT WORTH, TX 76134-2001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Ophthalmic preparationsABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2013MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Aug 1, 2013ABN5ABANDONMENT - AFTER PUBLICATION
Jul 30, 2013EXARTEAS EXPRESS ABANDONMENT RECEIVED
May 2, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Apr 2, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2013DOCKASSIGNED TO EXAMINER
Nov 2, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2012NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance